Please enable JavaScript to continue using this application.

Compare $ACRV vs $ATRA | Chartloom

Compare

$ACRV vs $ATRA

Acrivon Therapeutics Inc · Atara Biotherapeutics Inc

ACRV

Acrivon Therapeutics Inc

ATRA

Atara Biotherapeutics Inc

Compare $ACRV vs $ATRA

Comparing Acrivon Therapeutics Inc and Atara Biotherapeutics Inc

ACRVAcrivon Therapeutics Inc

ATRAAtara Biotherapeutics Inc

ACRVAcrivon Therapeutics Inc

Market cap

$82M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-22.4%

52W performance

1.6%

FCF yield

-78.5%

ATRAAtara Biotherapeutics Inc

Market cap

$85M

P/E (TTM)

—

Forward P/E (NTM)

14.78x

Forward P/S (NTM)

2.47x

Rev growth (TTM)

-96.7%

YTD performance

-46.7%

52W performance

-40.2%

FCF yield

-25.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ACRV

ATRA

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

ATRA

Atara Biotherapeutics Inc

Market Cap

ACRV$82M

ATRA$85M

Enterprise Value

ACRV$40M

ATRA$124M

Price

ACRV$1.91

ATRA$9.48

P/E Ratio

ACRVN/A

ATRAN/A

P/S Ratio

ACRV0.00x

ATRA13.79x

EV/Sales

ACRV0.00x

ATRA19.98x

EV/EBITDA

ACRV0.00x

ATRA3.51x

P/B Ratio

ACRV0.98x

ATRA12.86x

P/FCF Ratio

ACRVN/A

ATRAN/A

EV/FCF

ACRV-0.63x

ATRA-5.65x

PEG Ratio

ACRVN/A

ATRAN/A

Forward P/E (NTM)

ACRVN/A

ATRA14.78x

Forward P/S (NTM)

ACRVN/A

ATRA2.47x

Revenue (TTM)

ACRV$0

ATRA$6M

Revenue Growth (YoY)

ACRVN/A

ATRA-96.7%

Forward Rev Growth

ACRV406.9%

ATRA1983.2%

Gross Margin (TTM)

ACRV0.0%

ATRA91.4%

Operating Margin (TTM)

ACRV0.0%

ATRA0.0%

EBITDA Margin (TTM)

ACRV0.0%

ATRA-194.7%

Net Margin (TTM)

ACRV0.0%

ATRA-269.4%

FCF Margin (TTM)

ACRVN/A

ATRA-353.5%

Net Income (TTM)

ACRV$-74M

ATRA$-17M

FCF (TTM)

ACRV$-64M

ATRA$-22M

EPS (TTM)

ACRV-$1.77

ATRA-$1.11

ROE (TTM)

ACRV-7014.0%

ATRA-31542.0%

ROA (TTM)

ACRV-6161.0%

ATRA-7301.0%

ROIC (TTM)

ACRV-7014.0%

ATRA-30684.0%

Cash

ACRV$41M

ATRA$3M

Debt

ACRV$0

ATRA$42M

Net Cash/Debt

ACRV$41M

ATRA$-38M

Current Ratio (TTM)

ACRV7.99x

ATRA1.98x

Quick Ratio (TTM)

ACRV7.86x

ATRA1.98x

Debt/Equity (TTM)

ACRV0.00x

ATRA0.12x

Debt/Assets (TTM)

ACRV0.0%

ATRA0.0%

Interest Coverage (TTM)

ACRVN/A

ATRAN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

ATRA0.00x

Beta

ACRV1.95

ATRA0.31

52W Performance

ACRV1.6%

ATRA-40.2%

YTD Performance

ACRV-22.4%

ATRA-46.7%

% from 52W High

ACRV-46.3%

ATRA-50.5%

% from 52W Low

ACRV50.4%

ATRA141.8%

Asset Turnover (TTM)

ACRV0.00x

ATRA0.27x

FCF Yield (TTM)

ACRV-78.5%

ATRA-25.6%

Earnings Yield (TTM)

ACRV-90.8%

ATRA-19.5%

Dividend Yield (TTM)

ACRVN/A

ATRAN/A

Rule of 40

ACRV0.0

ATRA-450.2

EV/GP/RG

ACRVN/A

ATRA0.05

Ticker research

View ACRV research View ATRA research

Metric	ACRV Acrivon Therapeutics Inc	ATRA Atara Biotherapeutics Inc
Market & Valuation
Market Cap	$82M	$85M
Enterprise Value	$40M	$124M
Price	$1.91	$9.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.79x
EV/Sales	0.00x	19.98x
EV/EBITDA	0.00x	3.51x
P/B Ratio	0.98x	12.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-5.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	14.78x
Forward P/S (NTM)	N/A	2.47x
Revenue & Growth
Revenue (TTM)	$0	$6M
Revenue Growth (YoY)	N/A	-96.7%
Forward Rev Growth	406.9%	1983.2%
Profitability
Gross Margin (TTM)	0.0%	91.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-194.7%
Net Margin (TTM)	0.0%	-269.4%
FCF Margin (TTM)	N/A	-353.5%
Net Income (TTM)	$-74M	$-17M
FCF (TTM)	$-64M	$-22M
EPS (TTM)	-$1.77	-$1.11
ROE (TTM)	-7014.0%	-31542.0%
ROA (TTM)	-6161.0%	-7301.0%
ROIC (TTM)	-7014.0%	-30684.0%
Financial Health
Cash	$41M	$3M
Debt	$0	$42M
Net Cash/Debt	$41M	$-38M
Current Ratio (TTM)	7.99x	1.98x
Quick Ratio (TTM)	7.86x	1.98x
Debt/Equity (TTM)	0.00x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.31
52W Performance	1.6%	-40.2%
YTD Performance	-22.4%	-46.7%
% from 52W High	-46.3%	-50.5%
% from 52W Low	50.4%	141.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.27x
FCF Yield (TTM)	-78.5%	-25.6%
Earnings Yield (TTM)	-90.8%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-450.2
EV/GP/RG	N/A	0.05
Ticker research	View ACRV research	View ATRA research

Valuation

P/S Ratio

ACRV

0.00x

ATRA

13.79x

EV/FCF

ATRA

-5.65x

ACRV

-0.63x

Growth & revenue

Revenue Growth TTM

ATRA

-96.7%

Forward Revenue Growth

ATRA

1983.2%

ACRV

406.9%

Profitability & performance

Gross Margin

ATRA

91.4%

ACRV

0.0%

ROE

ACRV

-7014.0%

ATRA

-31542.0%

FCF Yield %

ATRA

-25.6%

ACRV

-78.5%

52-Week Performance

ACRV

1.6%

ATRA

-40.2%

Detailed metrics comparison

ACRV

Acrivon Therapeutics Inc

ATRA

Atara Biotherapeutics Inc

Market Cap

ACRV$82M

ATRA$85M

Enterprise Value

ACRV$40M

ATRA$124M

Price

ACRV$1.91

ATRA$9.48

P/E Ratio

ACRVN/A

ATRAN/A

P/S Ratio

ACRV0.00x

ATRA13.79x

EV/Sales

ACRV0.00x

ATRA19.98x

EV/EBITDA

ACRV0.00x

ATRA3.51x

P/B Ratio

ACRV0.98x

ATRA12.86x

P/FCF Ratio

ACRVN/A

ATRAN/A

EV/FCF

ACRV-0.63x

ATRA-5.65x

PEG Ratio

ACRVN/A

ATRAN/A

Forward P/E (NTM)

ACRVN/A

ATRA14.78x

Forward P/S (NTM)

ACRVN/A

ATRA2.47x

Revenue (TTM)

ACRV$0

ATRA$6M

Revenue Growth (YoY)

ACRVN/A

ATRA-96.7%

Forward Rev Growth

ACRV406.9%

ATRA1983.2%

Gross Margin (TTM)

ACRV0.0%

ATRA91.4%

Operating Margin (TTM)

ACRV0.0%

ATRA0.0%

EBITDA Margin (TTM)

ACRV0.0%

ATRA-194.7%

Net Margin (TTM)

ACRV0.0%

ATRA-269.4%

FCF Margin (TTM)

ACRVN/A

ATRA-353.5%

Net Income (TTM)

ACRV$-74M

ATRA$-17M

FCF (TTM)

ACRV$-64M

ATRA$-22M

EPS (TTM)

ACRV-$1.77

ATRA-$1.11

ROE (TTM)

ACRV-7014.0%

ATRA-31542.0%

ROA (TTM)

ACRV-6161.0%

ATRA-7301.0%

ROIC (TTM)

ACRV-7014.0%

ATRA-30684.0%

Cash

ACRV$41M

ATRA$3M

Debt

ACRV$0

ATRA$42M

Net Cash/Debt

ACRV$41M

ATRA$-38M

Current Ratio (TTM)

ACRV7.99x

ATRA1.98x

Quick Ratio (TTM)

ACRV7.86x

ATRA1.98x

Debt/Equity (TTM)

ACRV0.00x

ATRA0.12x

Debt/Assets (TTM)

ACRV0.0%

ATRA0.0%

Interest Coverage (TTM)

ACRVN/A

ATRAN/A

Net Debt/EBITDA (TTM)

ACRV0.00x

ATRA0.00x

Beta

ACRV1.95

ATRA0.31

52W Performance

ACRV1.6%

ATRA-40.2%

YTD Performance

ACRV-22.4%

ATRA-46.7%

% from 52W High

ACRV-46.3%

ATRA-50.5%

% from 52W Low

ACRV50.4%

ATRA141.8%

Asset Turnover (TTM)

ACRV0.00x

ATRA0.27x

FCF Yield (TTM)

ACRV-78.5%

ATRA-25.6%

Earnings Yield (TTM)

ACRV-90.8%

ATRA-19.5%

Dividend Yield (TTM)

ACRVN/A

ATRAN/A

Rule of 40

ACRV0.0

ATRA-450.2

EV/GP/RG

ACRVN/A

ATRA0.05

Ticker research

View ACRV research View ATRA research

Metric	ACRV Acrivon Therapeutics Inc	ATRA Atara Biotherapeutics Inc
Market & Valuation
Market Cap	$82M	$85M
Enterprise Value	$40M	$124M
Price	$1.91	$9.48
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	13.79x
EV/Sales	0.00x	19.98x
EV/EBITDA	0.00x	3.51x
P/B Ratio	0.98x	12.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.63x	-5.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	14.78x
Forward P/S (NTM)	N/A	2.47x
Revenue & Growth
Revenue (TTM)	$0	$6M
Revenue Growth (YoY)	N/A	-96.7%
Forward Rev Growth	406.9%	1983.2%
Profitability
Gross Margin (TTM)	0.0%	91.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-194.7%
Net Margin (TTM)	0.0%	-269.4%
FCF Margin (TTM)	N/A	-353.5%
Net Income (TTM)	$-74M	$-17M
FCF (TTM)	$-64M	$-22M
EPS (TTM)	-$1.77	-$1.11
ROE (TTM)	-7014.0%	-31542.0%
ROA (TTM)	-6161.0%	-7301.0%
ROIC (TTM)	-7014.0%	-30684.0%
Financial Health
Cash	$41M	$3M
Debt	$0	$42M
Net Cash/Debt	$41M	$-38M
Current Ratio (TTM)	7.99x	1.98x
Quick Ratio (TTM)	7.86x	1.98x
Debt/Equity (TTM)	0.00x	0.12x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.31
52W Performance	1.6%	-40.2%
YTD Performance	-22.4%	-46.7%
% from 52W High	-46.3%	-50.5%
% from 52W Low	50.4%	141.8%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.27x
FCF Yield (TTM)	-78.5%	-25.6%
Earnings Yield (TTM)	-90.8%	-19.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-450.2
EV/GP/RG	N/A	0.05
Ticker research	View ACRV research	View ATRA research